Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence

Prostate Cancer and Prostatic Diseases

Volumn 15, Issue 1, 2012, Pages 8-14

  Teishima, J ^a   Shoji, K ^a   Hayashi, T ^a   Miyamoto, K ^a   Ohara, S ^a   Matsubara, A ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

biochemical recurrence; cell invasion; FGF9; predictive factor; radical prostatectomy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FIBROBLAST GROWTH FACTOR 9;

ADULT; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL ASSAY; CELL INVASION; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECURRENCE FREE SURVIVAL; SURVIVAL RATE;

ADENOCARCINOMA; AGED; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; DISEASE-FREE SURVIVAL; FIBROBLAST GROWTH FACTOR 9; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84857050829     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2011.48     Document Type: Article

References (24)

1. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res 2007; 64: 4555-4562. (Pubitemid 38856928)
2. Wu X, Jin C, Wang F, Yu C, McKeehan WL. Stromal cell heterogeneity in fibroblast growth factor-mediated stromalepithelial cell cross-talk in premalignant prostate tumors. Cancer Res 2003; 63: 4936-4944. (Pubitemid 37022629)
3. Giri D, Ropiquet F, Ittmann M. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 1999; 180: 53-60. (Pubitemid 29249712)
4. Todo T, Kondo T, Kirino T, Asai A, Adams EF, Nakamura S et al. Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors. Neurosurgery 1998; 43: 337-346. (Pubitemid 28354646)
5. Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. Ovarian ca wnt Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 2006; 66: 1354-1362. (Pubitemid 43259914)
6. Wang CK, Chang H, Chen PH, Chang JT, Kuo YC, Ko JL et al. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas. Int J Cancer 2009; 125: 807-815.
7. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
8. Mori R, Dorff TB, Xiong S, Tarabolous CJ, Ye W, Groshen S et al. The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes. Prostate 2010; 70: 1692-1700.
9. Perez CA, Chen H, Shyr Y, Courtney R, ZhengW, Cai Q et al. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer. J Urol 2010; 183: 2062-2069.
10. Xu B, Mi YY, Min ZC, Cheng G, Tong N, Tao J et al. p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a Southern Chinese population. Urol Int 2010; 85: 401-405.
11. Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J et al. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 2008; 118: 2697-2710.
12. Ueng TH, Chang YL, Tsai YY, Su JL, Chan PK, Shih JY et al. Potential roles of fibroblast growth factor-9 in the benzo(a) pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma. Arch Toxicol 2010; 84: 651-660.
13. Ohara S, Oue N, Matsubara A, Mita K, Hasegawa Y, Hayashi T et al. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer. Cancer Sci 2008; 99: 1570-1577.
14. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H et al. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 1993; 53: 36-41. (Pubitemid 23018419)
15. Naruo K, Seko C, Kuroshima K, Matsutani E, Sasada R, Kondo T et al. Novel secretory heparin-binding factors from human glioma cells (glia-activating factors) involved in glial cell growth. Purification and biological properties. J Biol Chem 1993; 268: 2857-2864. (Pubitemid 23057920)
16. Robinson D, Hasharoni A, Oganesian A, Sandell LJ, Yayon A, Nevo Z. Role of FGF9 and FGF receptor 3 in osteochondroma formation. Orthopedics 2001; 24: 783-787. (Pubitemid 32791603)
17. Hiramatsu R, Harikae K, Tsunekawa N, Kurohmaru M, Matsuo I, Kanai Y. FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. Development 2010; 137: 303-312.
18. Schmahl J, Kim Y, Colvin JS, Ornitz DM, Capel B. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 2004; 131: 3627-3636. (Pubitemid 39199372)
19. Behr B, Leucht P, Longaker MT, Quarto N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci USA 2010; 107: 11853-11858.
20. Klein RD, Maliner-Jongewaard MS, Udayakumar TS, Boyd JL, Nagle RB, Bowden GT. Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells. Prostate 1999; 41: 215-223.
21. Miyagi N, Kato S, Terasaki M, Shigemori M, Morimatsu M. Fibroblast growth factor-2 and -9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Int J Oncol 1998; 12: 1085-1090. (Pubitemid 28186771)
22. Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, Epstein JI. Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system. J Urol 2009; 182: 1364-1370.
23. Hattab EM, Koch MO, Eble JN, Lin H, Cheng L. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol 2006; 175: 1695-1699.
24. Harada M, Murakami H, Okawa A, Okimoto N, Hiraoka S, Nakahara T et al. FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 2009; 41: 289-298.